Recruited phagocytes degranulate and release hydrolytic enzymes that cause tissue destruction and rapid rejection of the kidney. Hyperacute rejection most commonly occurs while the patient is ...

Chinese scientists used CRISPR/Cas9technology to locate the genes that cause hyperacute rejection to hopefully evade that problem in the kidney patient. At 13 days, the organ continues to function.

After T-cell activation, a soluble form of CD30 (sCD30) is released and can be measured in the serum sCD30 levels might help in identifying patients at higher risk of acute rejection Data ...

Recent advances using transgenic animals or exogenous complement inhibitors have demonstrated prevention of hyperacute rejection of vascularized organs, but not graft loss due to acute vascular ...